Antibiotic, Gingival-biopsy, and Oral-smear Samples.

Sponsor
Istanbul Medipol University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04172207
Collaborator
(none)
45
1
11
4.1

Study Details

Study Description

Brief Summary

Antimicrobial or antibiotic agents, which are essential to prevent and treat bacterial infectious diseases, have become one of the most widely used drugs in the world. In the European region, the highest rates of antibiotic consumption are reported in Turkey. There is a nearly fivefold difference between Turkey and the lowest consuming countries.

Studies in dentistry evaluate participants according to the basis of predefined criteria. History of antibiotic consumption is one of the most common exclusion criteria for periodontal trials. However, there is still disagreement on how long the effect of systemic antibiotic agents on the oral mucosa and periodontal tissue lasts. It is unclear whether the timing of antibiotic consumption should be an exclusion criterion for genetic damage and histological studies during the selection of healthy participants.

Periodontal status of participants in study groups is described as with or without periodontitis in many studies, because of the lack of clear definitions of periodontal health and gingivitis. It should be recognized that even the lack of visual signs of inflammation, some mild histopathological changes can be seen in the periodontium. Consequently, for the real diagnosis of the clinically healthy periodontium, clinical findings should be supported and confirmed with histological results.

Micronuclei (Mn) are observed as abnormal nuclear structures and indicators of chromosomal level DNA damage. The oral mucosa epithelium is an immunologic barrier and affected by chemical factors such as antibiotic consumption. The Mn test to exfoliated epithelial cells from the oral cavity is utilized as a non-invasive diagnostic technique for monitoring the status of oral health. To our knowledge, no studies have been conducted on the comparison of the impacts of the timing of antibiotic consumption on human periodontal tissues and oral smear samples. The present study is undertaken to determine whether the different timing of antibiotic (amoxicillin) therapy has effects on the histopathology of gingiva and genetic damage of exfoliated cells from oral mucosa in healthy participants.

Condition or Disease Intervention/Treatment Phase
  • Other: Sampling

Study Design

Study Type:
Observational
Actual Enrollment :
45 participants
Observational Model:
Other
Time Perspective:
Other
Official Title:
Effects of Antibiotic Consumption Time on Gingival-biopsy and Oral-smear Samples.
Actual Study Start Date :
Oct 15, 2018
Actual Primary Completion Date :
Jun 15, 2019
Actual Study Completion Date :
Sep 15, 2019

Arms and Interventions

Arm Intervention/Treatment
Results of study groups.

Other: Sampling
After periodontal parameters measured, smear samples were obtained from the buccal mucosa and keratinized gingiva, and then a gingival biopsy was performed from the upper premolars.

Outcome Measures

Primary Outcome Measures

  1. Effects of antibiotics on gingiva confirmed by histopathology. [1-week]

    Modified histological criteria was the measurement used for the semi-quantitative histological assessment of gingival damage. Cellular components, vascularization, cell infiltration, necrosis, pyknotic nucleus, hyperemia, fibrosis, ulceration, atrophy, apoptosis, and rete peg configuration were scored by using a scale ranging from 0 to 3 (none : 0, mild: 1, moderate: 2, and severe : 3) for each criterion.

  2. Effects of antibiotics on buccal and oral smear confirmed by quantitative determination of the micronuclei. [1-week]

    The method has been applied both for monitoring chromosome damage and/or proteins may also result in unsuccessful attachment of a whole chromosome at anaphase stage which subsequently also gives rise to a micronucleus. Thus, quantitative determination of the micronuclei are unique amongst cytogenetic tests in that it provides a reliable measure of both chromosome loss and breakage.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Systemically and periodontally healthy participants

  • Presence of probing depth (PD) of ≤ 3 mm14 and bleeding on probing (BOP) ˂ 10%15

  • No clinical evidence of gingival recession (GR), clinic attachment loss or radiographic evidence of alveolar bone loss

  • No periodontal treatment within the last 12 months

Exclusion Criteria:
  • Smoking, alcohol or drug abuse

  • Any systemic condition would affect the periodontal health (i.e., pregnancy, lactation, ovulation, and diabetes mellitus)

  • A history of contagious disease

  • Periodontal treatment within the last 12 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 Begum Alkan Istanbul Turkey 34230

Sponsors and Collaborators

  • Istanbul Medipol University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Begum Alkan, Principal Investigator, Istanbul Medipol University Hospital
ClinicalTrials.gov Identifier:
NCT04172207
Other Study ID Numbers:
  • Istanbul Medipol University
First Posted:
Nov 21, 2019
Last Update Posted:
Nov 26, 2019
Last Verified:
Nov 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 26, 2019